Clinical Trials on Heartburn in Austria
Total 3 results
-
AstraZenecaCompleted
-
NovartisCompleted
-
AstraZenecaCompletedEsophagitis | Heartburn | Reflux | RegurgitationSweden, Spain, Norway, Austria, Italy
Sponsors and Collaborators
- Axon Neuroscience SE
- Alessandra Palo
- Doterra Healing Hands Foundation
- Gregorio Covino
- CeRSM
- Outpatient Endovascular and Interventional Society
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- EMET Pharmaceuticals, LLC
- YASEMİN AYDIN KARTAL
- Eastman Kodak Company
- Saint Pierre Institute - Palavas les Flots
- Grünenthal Denmark ApS
- CARITAS Rundum zu Hause betreut
- Phramongkutklao College of Medicine and Hospital
- Invicta Medical Inc.
- Aga Khan Foundation, Pakistan
- Department of Anesthesiology, North Denmark Regional Hospital
- Yancheng City NO.1 People's Hospital
- Erzurum Regional Training & Research Hospital
- Irish Endocrine Society
- View Full List
Medical Conditions
- Human Risk Factors
- Ferritin Threshold
- Chondrosis
- Abdominal Compartment Syndrome
- Central Motor Disorders
- Mineralocorticoid Excess
- Neutrophilia Acute
- Osteopathic Manipulative Treatment
- Bioequivalence, AUC, Cmax, Pharmacokinetics
- Modality of Discharge Instructions
- Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)
- Venous Puncture
- Pelvic and Groin Areas Biopsy
- HIV Pre-exposure Prophylaxis Use
- Hypogonadism, Hypogonadotropic
- Skeletal Muscle Energy Metabolism
- Acute Endophthalmitis Post-operative
- Reading Disability
- Hemopathies
- Major Depressive Disorder, Recurrent Episode, Severe
- View Full List
Drug Interventions
- Carbetocin
- Risperidone
- Enteral oxygen therapy
- Neridronate
- Leuprolide acetate 11.25 mg
- Test varnish
- Betamethasone
- Niraparib
- Pregabalin
- Systemic intravenous lidocaine infusion
- Anti-PD1 antibody, nimotuzumab and capecitabine
- Pacritinib
- Naltrexone 50 Mg + Inactive Marijuana (0% THC)
- Ranitidine
- MYL-1501D product using manufacture process VI
- Amantadine Sulfate
- Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
- Lenalidomide
- LY2216684
- Apatinib
- View Full List
CROs by country
- Contract Research Organizations in Belgium
- Contract Research Organizations in Benin
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Croatia
- Contract Research Organizations in Estonia
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Malta
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Trinidad & Tobago
- CRO list by country